Exhibition style | CMEF2020·Aocheng Biotech is landing!

Categories:News Center
Author:
Origin:
Time of issue:2020-10-27
Views:0

(Summary description)The CMEF held in Shanghai has come to an end. In this grand event, Ningbo Aocheng unveiled its pre-eclampsia whole-pregnancy management program. The self-developed placental growth factor detection reagent is used as the best biomarker for pre-eclampsia prediction and management. Things are even more popular among professional audiences. Ningbo Aocheng has been independently researched and developed for ten years and is committed to providing professional maternal and child health solutions, including comprehensive solutions from platform, reagents, software to services, and jointly creating a new era of preeclampsia management with the clinic.

Exhibition style | CMEF2020·Aocheng Biotech is landing!

(Summary description)The CMEF held in Shanghai has come to an end. In this grand event, Ningbo Aocheng unveiled its pre-eclampsia whole-pregnancy management program. The self-developed placental growth factor detection reagent is used as the best biomarker for pre-eclampsia prediction and management. Things are even more popular among professional audiences. Ningbo Aocheng has been independently researched and developed for ten years and is committed to providing professional maternal and child health solutions, including comprehensive solutions from platform, reagents, software to services, and jointly creating a new era of preeclampsia management with the clinic.

Categories:News Center
Author:
Origin:
Time of issue:2020-10-27
Views:0

Conference Introduction

The CMEF held in Shanghai has come to an end. In this grand event, Ningbo Aocheng unveiled its pre-eclampsia whole-pregnancy management program. The self-developed placental growth factor detection reagent is used as the best biomarker for pre-eclampsia prediction and management. Things are even more popular among professional audiences. Ningbo Aocheng has been independently researched and developed for ten years and is committed to providing professional maternal and child health solutions, including comprehensive solutions from platform, reagents, software to services, and jointly creating a new era of preeclampsia management with the clinic.

If you also want to work hard for China’s maternal and child health, reduce the incidence of pregnancy-induced hypertension and preeclampsia in China, and achieve the goal of healthy China in 2030,Please work with Ao Cheng to pay attention to preeclampsia, placental growth factor, and the next tens of billions of new blue oceans after Down's screening!

Ao Cheng Bio shines CMEF

In this exhibition, Ningbo Aocheng featured the independently developed iRaTe series of fluorescent immunological quantitative detection technology platform, iSort series of microfluidic fluorescent immunological quantitative detection technology platform, and iMAGIN series of magnetic particle acridine lipid chemiluminescence detection technology platform, which are in vitro diagnostics The industry injects new vitality.

Aucheer iRaTe time-resolved fluorescence immunoquantitative detection system

iRaTe 300 single channel

Fluorescence immunoassay analyzer

iRaTe 1600 multi-channel

Fluorescence immunoassay analyzer

Aucheer iRaTe time-resolved fluorescence immunoquantitative detection system

i-Sort 300

Microfluidic Fluorescence Immunoassay Quantitative Analyzer

i-Sort 2000 microfluidics

Automatic fluorescence immunoassay analyzer

iMAGIN Magnetic Particle Acridine Lipid Chemiluminescence Detection Technology Platform

iMAGIN 1800 magnetic particle acridine lipid automatic chemiluminescence analyzer

Aucheer iRaTe PLGF detection reagent

As a special project of Ningbo Aocheng, the placental growth factor (PLGF) test kit is used for the whole pregnancy management of preeclampsia, and it is also favored by guests. Placental growth factor testing was also recommended by the “Practical Guidelines for Early Preeclampsia Screening and Prevention” issued by the International Federation of Obstetrics and Gynecology (FIGO) on June 18, 2019, opening a new era of pre-eclampsia risk assessment and management. The guidelines recommend that all pregnant women undergo placental growth factor testing in the first trimester. Combining maternal factors, MAP, and UTPI can effectively predict the occurrence of preeclampsia.Ningbo Aocheng brings the latest maternal and child health solutions to this grand event!

Conference Scene

About Aocheng

Ningbo Aocheng Biotechnology Co., Ltd. is a high-tech biological enterprise focusing on the early detection, diagnosis, prevention and monitoring of diseases. By providing reliable, fast and convenient in vitro diagnostic products, it can provide accurate test results for diagnosis and treatment.

At present, the company's biomedical team continues to conduct in-depth exploration and prospective research in the field of high-risk diseases for pregnant women such as hypertension.We will be committed to providing leading clinical diagnosis solutions for women and children's health. Promote the standardized management of perinatal preeclampsia in my country, and make contributions to the predictive management of preeclampsia in the world.